Literature DB >> 16095472

Cognitive-behavioral group therapy for obsessive-compulsive disorder: a 1-year follow-up.

D T Braga1, A V Cordioli, K Niederauer, G G Manfro.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the results of cognitive-behavioral group therapy (CBGT) for obsessive-compulsive disorder (OCD) over a 1-year follow-up period.
METHOD: Forty-two OCD patients, who completed 12 sessions of CBGT, were followed for 1 year. Measures of the severity of symptoms were obtained at the end of the acute treatment and at 3, 6, and 12 months post-treatment using the Yale-Brown obsessive-compulsive scale (Y-BOCS) and the clinical global impression (CGI).
RESULTS: The reduction in the severity of symptoms observed at the end of the treatment was maintained during 1 year (F2,41=1.1; P=0.342). Eleven patients (35.5%) relapsed in the follow-up period. The intensity of improvement (log rank=12.97, GL=1, P=0.0003) and full remission (log rank=6.17; GL=1; P=0.001) were strong predictors for non-relapsing.
CONCLUSION: The CBGT is an effective treatment for OCD and its results are maintained for 1 year. However, further long-term randomized controlled trials are needed in order to confirm this finding. Copyright (c) 2005 Blackwell Munksgaard

Entities:  

Mesh:

Year:  2005        PMID: 16095472     DOI: 10.1111/j.1600-0447.2005.00559.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  2 in total

1.  Latinos with obsessive-compulsive disorder: Mental healthcare utilization and inclusion in clinical trials.

Authors:  Chad T Wetterneck; Tannah E Little; Kimberly L Rinehart; Maritza E Cervantes; Emma Hyde; Monnica Williams
Journal:  J Obsessive Compuls Relat Disord       Date:  2012-01-08       Impact factor: 1.677

2.  Effect of Religious Cognitive Behavioral Therapy on Religious Obsessive-compulsive Disorder (3 and 6 months Follow-up).

Authors:  Shahla Aouchekian; Roya Karimi; Mostafa Najafi; Katayon Shafiee; Mohammadreza Maracy; Asiyeh Almasi
Journal:  Adv Biomed Res       Date:  2017-12-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.